We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, clearing the way for a clinical trial. Read More
The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial. Read More
Philip Morris and British American Tobacco (BAT) have entered the race for a COVID-19 vaccine in collaboration with two biotech firms working on plant-based vaccines. Read More
CSIRO was the first research organization outside of China to generate sufficient stock of the virus to enable pre-clinical studies of COVID-19. Read More